Ede Márványos

Title: Ede Márványos: Innovator in Pharmaceutical Chemistry

Introduction

Ede Márványos is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the treatment of insulin resistance and vascular diseases. With a total of 2 patents, his work has the potential to impact the medical community significantly.

Latest Patents

Márványos's latest patents include innovative compounds aimed at addressing critical health issues. One of his patents is for N-[2-hydroxy-3-(1-piperidinyl)propoxy]pyridine-1-oxide-3-carboximidoyl chloride and its use in the treatment of insulin resistance. This invention encompasses methods for treating pathological insulin resistance and associated conditions, including diabetes-induced complications such as retinopathy, neuropathy, and nephropathy. Another significant patent involves an optically active pyridyl-4H-1,2,4-oxadiazine derivative, specifically designed for the treatment of vascular diseases. This compound, (-)-5,6-dihydro-5-(1-piperidinyl)-methyl-3-(3-pyridyl)-4H-1,2,4-oxadiazine, is intended for therapeutic use and is included in pharmaceutical compositions.

Career Highlights

Throughout his career, Ede Márványos has worked with various organizations, including Biorex Kutató és Fejlesztő Rt. His expertise in pharmaceutical research has led to the development of groundbreaking treatments that address significant health challenges.

Collaborations

Márványos has collaborated with several professionals in his field, including Zita Csákai and Jenő Szilbereky. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Ede Márványos is a distinguished inventor whose work in pharmaceutical chemistry has the potential to transform treatment options for insulin resistance and vascular diseases. His innovative patents reflect his commitment to improving health outcomes through scientific research and collaboration.